Nivolumab plus cabozantinib (N+C) vs sunitinib (S) for previously untreated advanced renal cell carcinoma (aRCC): Final follow-up results from the CheckMate 9ER trial. Casdatifan (Cas) monotherapy in ...
Get outside of the mosquito netting and prevent bug bites with the best bug repellents chosen by our experts. Cookouts, hikes and lounging by the pool might all be on your warm-weather wish list ...
Outcomes of different therapeutic modalities for patients with metachronous oligometastatic renal-cell carcinoma (RCC): Analyses of a single-institution database.
Dr. Kathryn E. Beckermann presented KEYMAKER-U03 Substudy 03B of pembrolizumab plus targeted therapy combination for advanced clear cell renal cell carcinoma (ccRCC). Despite high response rates, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results